Clinical Trials Logo

Clinical Trial Summary

The primary aim of this study is to exploit a difference between COPD patients, chronic smokers without COPD and healthy non-smoking subjects. This will help to assess the utility of inflammatory and oxidative markers in exhaled air and sputum and to compare them with the lung function, clinical parameters and computerised tomography (CT).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT00180622
Study type Observational
Source Imperial College London
Contact
Status Withdrawn
Phase
Start date July 1, 2001
Completion date July 1, 2002

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05980611 - Nasal IL 1 Beta ,IL 3 Level and Their Effects in COPD Patients
Recruiting NCT00949195 - Pulmonary Arterial Pressure Response During Exercise N/A
Completed NCT06128902 - The Effect of Home-Based Monitoring, Exercise Training N/A
Completed NCT01475812 - Daily Activities Are Sufficient to Induce Dynamic Pulmonary Hyperinflation and Dyspnea in Chronic Obstructive Pulmonary Disease Patients N/A
Completed NCT02157935 - Comparing the Efficacy of Symbicort® pMDI and Formoterol Turbuhaler in Reducing Exacerbations in Patients With Cronic Obstructive Pulmonary Disease Phase 3
Completed NCT01183052 - Mitochondrial Dysfunction and Oxidative Stress in Chronic Obstructive Pulmonary Disease (COPD) Patients N/A
Completed NCT04869033 - Effects of Farinelli's Breathing Exercise in COPD Patients N/A
Completed NCT02099279 - Prognostic Value Cardiac Dysfunction Assessed by Bedside Echocardiography in Critically Ill COPD Patients Requiring Mechanical Ventilation N/A
Withdrawn NCT00361426 - EarlySense Monitoring Device Evaluation on COPD, CHF and Pneumonia Patients N/A
Recruiting NCT03774238 - Determinants of the Vascular Response to Training in Chronic Obstructive Pulmonary Disease (COPD) Patients N/A
Enrolling by invitation NCT03851991 - The Efficacy and Safety of Arbidol in Reducing the Frequency of AECOPD. Phase 4